The US Alcohol and Tobacco Tax and Trade Bureau (TTB) warned alcoholic drinks manufacturers to limit the use of the word "clean" to describe a flavor, not to imply health claims.
All alcoholic beverages must also bear a health risk warning, according to the TTB's existing labeling requirements, and the word "clean" isn't a method to soften that message.
The TTB admitted that its regulations do not define the word 'clean,' and that they do not have standards for the use of the term on labels or in advertisements.
It warned that consumers should not interpret the term as meaning that the beverage is organic or has met other production standards set by TTB.
The TTB noted that the word clean is being used along with other teams to create the misleading impression that consuming the alcoholic beverage will have health benefits, or that the health risks of alcohol consumption will be mitigated.


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Supreme Court Signals Doubts Over Trump’s Bid to Fire Fed Governor Lisa Cook
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
Federal Judge Restores Funding for Gateway Rail Tunnel Project
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



